Senior Director, Clinical Development, Pulmovant
Pulmovant· Remote, US
remote · country director seen live 15h ago
Pulmovant is a Roivant-backed clinical-stage biotechnology company committed to transforming the lives of patients with pulmonary diseases. Pulmovant’s first investigational candidate, mosliciguat, is designed to provide a novel, once-daily, inhaled treatment option for patients
This link goes straight to the employer's greenhouse page. Posted 12 days ago.We last confirmed it was open 15h ago.